Samer E. Kaba

2.4k total citations
11 papers, 414 citations indexed

About

Samer E. Kaba is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Samer E. Kaba has authored 11 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 4 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Samer E. Kaba's work include Multiple Sclerosis Research Studies (4 papers), Glioma Diagnosis and Treatment (4 papers) and Retinal and Optic Conditions (2 papers). Samer E. Kaba is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Glioma Diagnosis and Treatment (4 papers) and Retinal and Optic Conditions (2 papers). Samer E. Kaba collaborates with scholars based in United States. Samer E. Kaba's co-authors include Athanassios P. Kyritsis, Lawrence Jacobs, W. K. Alfred Yung, Victor A. Levin, Frederick Munschauer, Kurt A. Jaeckle, Janet M. Bruner, Franco DeMonte, Roger L. Priore and Colleen Miller and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Annals of Neurology.

In The Last Decade

Samer E. Kaba

10 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samer E. Kaba United States 8 155 116 114 84 73 11 414
Isabella Mammi Italy 13 169 1.1× 54 0.5× 69 0.6× 93 1.1× 113 1.5× 29 551
Anna Clerico Italy 16 202 1.3× 82 0.7× 63 0.6× 74 0.9× 222 3.0× 35 590
John David Tesoro-Tess Italy 10 162 1.0× 51 0.4× 77 0.7× 122 1.5× 78 1.1× 16 399
Atsufumi Kawamura Japan 9 133 0.9× 45 0.4× 103 0.9× 113 1.3× 87 1.2× 39 346
S. C. Bauserman United States 9 157 1.0× 74 0.6× 121 1.1× 280 3.3× 130 1.8× 12 476
Özlem Yapıcıer Türkiye 10 136 0.9× 119 1.0× 50 0.4× 133 1.6× 75 1.0× 63 416
Hirotomo Tanaka Japan 13 198 1.3× 38 0.3× 140 1.2× 211 2.5× 184 2.5× 35 611
Edward Kachur Canada 12 145 0.9× 111 1.0× 94 0.8× 249 3.0× 49 0.7× 25 624
Stephen G. Romansky United States 11 73 0.5× 60 0.5× 60 0.5× 21 0.3× 133 1.8× 23 420
Giuseppe Isimbaldi Italy 11 61 0.4× 30 0.3× 70 0.6× 62 0.7× 56 0.8× 33 372

Countries citing papers authored by Samer E. Kaba

Since Specialization
Citations

This map shows the geographic impact of Samer E. Kaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer E. Kaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer E. Kaba more than expected).

Fields of papers citing papers by Samer E. Kaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer E. Kaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer E. Kaba. The network helps show where Samer E. Kaba may publish in the future.

Co-authorship network of co-authors of Samer E. Kaba

This figure shows the co-authorship network connecting the top 25 collaborators of Samer E. Kaba. A scholar is included among the top collaborators of Samer E. Kaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer E. Kaba. Samer E. Kaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mansour, Sam E., Daniel F. Kiernan, Daniel B. Roth, et al.. (2020). Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study. British Journal of Ophthalmology. 105(3). 414–419. 23 indexed citations
3.
Collins, Barbara, et al.. (2004). Dementia with Lewy Bodies. Clinical Neuropharmacology. 27(6). 281–292. 4 indexed citations
4.
Kaba, Samer E. & Athanassios P. Kyritsis. (1997). Recognition and Management of Gliomas. Drugs. 53(2). 235–244. 41 indexed citations
5.
Fuller, Gregory N., Samer E. Kaba, Lawrence E. Ginsberg, Ian E. McCutcheon, & Lauren A. Langford. (1997). Late sequelae of treated pleomorphic xanthoastrocytoma: Malignant brain stem astrocytoma occurring 15 years after radiation therapy. Journal of Neuro-Oncology. 32(1). 57–61. 6 indexed citations
6.
Kaba, Samer E., Athanassios P. Kyritsis, Charles A. Conrad, et al.. (1997). The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin). Journal of Neuro-Oncology. 34(2). 145–151. 45 indexed citations
7.
Jacobs, Lawrence, Samer E. Kaba, Colleen Miller, Roger L. Priore, & Carol M. Brownscheidle. (1997). Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Annals of Neurology. 41(3). 392–398. 65 indexed citations
8.
Kaba, Samer E., Franco DeMonte, Janet M. Bruner, et al.. (1997). The Treatment of Recurrent Unresectable and Malignant Meningiomas with Interferon Alpha-2B. Neurosurgery. 40(2). 271–275. 109 indexed citations
9.
Kaba, Samer E., Athanassios P. Kyritsis, Kenneth R. Hess, et al.. (1997). TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.. Journal of Clinical Oncology. 15(3). 1063–1070. 41 indexed citations
10.
Munschauer, Frederick, Carleton C. Stewart, Lawrence Jacobs, et al.. (1993). Circulating CD3+ CD4+ CD+ T lymphocytes in multiple sclerosis. Journal of Clinical Immunology. 13(2). 113–118. 32 indexed citations
11.
Jacobs, Lawrence, Frederick Munschauer, & Samer E. Kaba. (1991). Clinical and magnetic resonance imaging in optic neuritis. Neurology. 41(1). 15–15. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026